Scientists have developed a new type of CAR T-cell therapy that could finally take on stubborn solid tumors like brain and prostate cancer. Called EchoBack CAR T-cells, these immune cells are activated by short bursts of focused ultrasound, which helps them last longer, attack tumors more effectively, and avoid harming healthy tissue. Regular CAR T-cell therapy works well for some blood cancers but struggles with solid tumors because the cells often tire out, disappear too quickly, or mistakenly

At LifeWorks, we take the guesswork out of cancer treatment. Using advanced tumor sensitivity testing, we separate circulating tumor stem cells from healthy blood cells and expose them to dozens of chemotherapy drugs in a controlled lab environment. Each drug is tested to see how effectively it kills the cancer cells. For example, if a sample starts with 1,000 cells and only 200 remain after a week, that drug achieved an 80% kill rate—a strong indicator it will work for that patient. Some drugs